Current through Register Vol. 46, No. 25, June 18, 2024
Section 58-2.19 - Records to be kept when derivatives are infusedThe following information shall be included on the recipient's chart or in records maintained in the blood bank or pharmacy:
(a) product name, manufacturer, lot number, and expiration date;(b) documentation of visual inspection prior to infusion;(c) name of person administering the product;(d) documentation of identification of the recipient;(e) date of infusion and quantity of material infused; and(f) description of any adverse reaction and the results of related investigation.N.Y. Comp. Codes R. & Regs. Tit. 10 § 58-2.19
Amended New York State Register July 29, 2015/Volume XXXVII, Issue 30, eff.9/27/2015